GLP-1 enrollment historically peaks at the start of the year, when employees activate new benefits and reset health goals, which means January and February are our highest-volume months
Set BAC water for a clean syringe draw 2.5 mL is the default: If the KLOW vial is 5+ mL in size rather than the standard 3 mL size, double the BAC water amount to 5 mL and syringe units for easier, more accurate dosing
As research continues, we'll learn even more about how these medications work and who they can help
How does adding glucagon to GLP-1 and GIP help
GLP-1 RAs are currently being investigated for various new areas, such as cardiovascular diseases, non-alcoholic steatohepatitis (NASH), Alzheimers disease, and chronic kidney disease
Retatrutide (LY3437943), developed by Eli Lilly, is an investigational once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously